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b1 integrins: zip codes and signaling relay for blood cells
Michael Sixt, Martina Bauer, Tim Lämmermann and Reinhard FässlerAt least eight of the twelve known members of the b1 integrin
family are expressed on hematopoietic cells. Among these, the
VCAM-1 receptor a4b1 has received most attention as a main
factor mediating firm adhesion to the endothelium during blood
cell extravasation. Therapeutic trials are ongoing into the use of
antibodies and small molecule inhibitors to target this
interaction and hence obtain anti-inflammatory effects.
However, extravasation is only one possible process that is
mediated by b1 integrins and there is evidence that they also
mediate leukocyte retention and positioning in the tissue,
lymphocyte activation and possibly migration within the
interstitium. Genetic mouse models where integrins are
selectively deleted on blood cells have been used to investigate
these functions and further studies will be invaluable to critically
evaluate therapeutic trials.
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Introduction
To fulfill their surveillance function immune cells con-
tinuously patrol the organism, shuttling back and forth
between the blood stream, the lymphatic fluid, secondary
lymphatic organs and peripheral tissues [1]. This mobile
life style requires flexible switching between passive
transport and various cell-to-cell and cell-to-extracellular
matrix (ECM) interactions to arrest, migrate and become
activated.
The current paradigm of cell locomotion within tissues
and along cell surfaces involves integrin-mediated adhe-
sion to ECM or cellular counter-receptors, which gener-
ates traction forces necessary for translocation of the cell
body [2]. Integrins are perfectly suited to this task since
they link the cytoskeleton with the extracellular environ-
ment. Integrins are heterodimeric cell surface receptors
made up of a and b subunits. The combination of 18
known a and 8 b subunits in mammals can give rise to 24Current Opinion in Cell Biology 2006, 18:482–490different receptors [3]. Antibody blocking studies, gene
targeting approaches in mice and investigation of human
diseases have unambiguously revealed that integrins are
essential for intact hematopoietic development, home-
ostasis and inflammation. However, integrin ligand bind-
ing can affect several cellular events in addition to
adhesion and migration, including cell differentiation,
polarization, activation and survival [3]. A drawback of
most studies manipulating integrin functions on blood
cells in vivo is that the cell-biological process affected by
the manipulation is not exactly defined. This is especially
evident when complex inflammatory models (for example
for autoimmune diseases) are studied and clinical symp-
toms or histological parameters are used as readout. A
further critical issue is that within recent years an increas-
ing number of mouse knockout studies have been pub-
lished that address the in vivo function of cytoplasmic
proteins involved in integrin signaling without explicitly
investigating which integrins are affected.
In this review we focus on the largest integrin family
which contains the b1 chain. The blood-cell-specific b2
integrin subfamily has been extensively reviewed by
others [4]. We will try to dissect the different cell-biolo-
gical functions that b1 integrins mediate when leukocytes
emerge from the blood vessels, locate within tissues,
become activated and re-enter the blood circulation.
Extravasation from the blood circulation
One of the best-established concepts in leukocyte biology
is the extravasation paradigm. When hematopoietic cells
leave the blood stream they go through a sequential
adhesion cascade to overcome both the high shear forces
within the blood vessel and the tight seal of the endothe-
lial cells (see Figure 1). Transient selectin–carbohydrate
interactions cause hematopoietic cells to begin to roll
along an activated endothelium. While rolling, the cells
sense chemokines that are immobilized on heparan sul-
fate residues on the luminal side of the endothelial cells.
The ligated chemokine receptors then transmit signals
into the leukocyte that lead to the rapid activation of
integrins (inside-out signaling — see Box 1), which
results in the integrins adhering firmly to their counter
receptors on the endothelial cell. Although adhesion
during extravasation is an essential step during leukocyte
trafficking, it has little in common with cell migration in
the true sense. It is rather a cell adhesion event of the
hematopoietic cell to the two-dimensional surface of the
endothelial lumen.
The crucial b1 integrin family member involved in extra-
vasation is a4b1, which binds to the endothelial Igwww.sciencedirect.com
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Box 1 Regulation of b1 integrin activation
On circulating leukocytes, integrins are locked in the low-affinity
state. Only upon ‘inside out’ signaling (triggered, for example, by
chemokines, growth factors or T cell receptor activation) integrins
adopt a high-affinity conformation (termed integrin activation)
facilitating ligand binding and subsequent cell adhesion. Ligand
binding in turn induces integrin ‘outside in’ signaling that (among
many other effects) further consolidates cell binding by clustering
the integrins and thereby increasing binding avidity. Cytoplasmic
key players mediating ‘inside-out’ signaling are the small GTPases
of the Rap family and talin.
Rap1: Several recent in vitro studies have proven that Rap1, the
best-characterized member of the five Rap proteins, is essential for
b1 integrin activation on leukocytes. Studies with cell lines revealed
that activated Rap1 increases b1 integrin-mediated adhesion and
migration on VCAM-1 via a4b1 and on fibronectin via a4b1 and
a5b1 [57,58]. The same was shown for primary thymocytes of
transgenic mice expressing the constitutively active Rap1-mutant
Rap1V12 [59], whereas T and B cells derived from Rap1-deficient
mice show impaired adhesion on fibronectin [60]. Rap1 is recruited
to the plasma membrane by PKD1, where it is activated upon
integration into a complex containing the b1 integrin cytoplasmic tail
[61,62]. For Rap1-mediated inside-out signaling, the two Rap1
binding effectors RIAM and RAPL are essential. Accordingly, T cells
and dendritic cells from RAPL-deficient mice show impaired
adhesion to b1 integrin ligands and reduced transmigration through
endothelial monolayers [63]. Overexpression of RIAM enhances
Rap1-mediated T cell adhesion to fibronectin. Through its interac-
tion with profilin and ENA/Vasp proteins, RIAM probably links
Rap1–GTP to the actin cytoskeleton [64].
Talin: Talin is a large rod-like molecule that binds via its globular
head domain to the membrane proximal NPXY motif of b integrins
in a phosphorylation-regulated manner. Talin acts as a physical
link between integrins and the actin cytoskeleton and its binding to
integrin b chains is regarded as the final common step in integrin
activation [65]. Two recent studies assessed the in vivo role of the
b1 integrin NPXY motifs by employing mouse genetic models.
They revealed that the intact conformation of the NPXY motifs are
essential, as substitution of the tyrosines by alanine abolishes b1
integrin function and leads to a b1 integrin-null phenotype [66,67].
Accordingly, chimeric mice with alanine substitutions, similar to a
b1 integrin-null chimera, fail to develop hematopoietic cells,
probably as a result of impaired talin binding [67]. Both studies,
however, challenged the former view that tyrosine phosphorylation
is essential for affinity regulation of b1 integrins, as replacement of
both cytoplasmic tyrosines with phenylalanine did not result in an
obvious phenotype, indicating that tyrosine phosphorylation is
dispensable for the physiological b1 integrin function in vivo.superfamily cell surface receptor VCAM-1 (vascular cell
adhesion molecule 1). This interaction is conserved in
many different physiological settings where extravasation
occurs. In the steady state, lymphocyte recirculation via
high endothelial venules [5], T cell precursor entry into
the thymus [6] and T cell and stem cell homing into the
bone marrow [7–9] are regulated via this pathway. During
inflammation, lymphocytes and monocytes use a4b1 to
immigrate into the skin, lung, peritoneum and liver
[10,11,12]. For several cell types it has also been shown
that VCAM-1-a4b1 binding can mediate not only firm
adhesion but also rolling along the endothelium [12]. In a
somewhat controversial deviation from the paradigm,www.sciencedirect.comthere is evidence that extravasation of lymphocytes into
the central nervous system during autoimmune inflam-
mation is possible in the absence of previous rolling
[13,14]. Here the cells can be rather abruptly captured
by VCAM-1 exposed on the endothelial lumen.
In most cases the function of a4b1 is partially redundant
with that of b2 integrins and a4b7, which bind the
endothelial counter-receptors intercellular adhesion
molecule (ICAM-1) and mucosal addressin cell adhesion
molecule-1 (MAdCAM-1), respectively. An impressive
example of this redundancy is lymphocyte recirculation
into lymph nodes, which is only partially affected by b2
and b7 elimination [5] and unimpaired in the absence of
b1 integrin [15]. Combined blockade, however, results in
almost 100% reduction of lymphocyte recirculation [5].
Many details concerning the overlapping functions of
these integrins remain to be clarified using genetic mod-
els in which the separate families are targeted
simultaneously.
Important exceptions to this redundancy are T cell traf-
ficking into the CNS, which is largely inhibitable by a4b1
blockade [16], stem cell homing into the bone marrow,
which is completely defective in the absence of b1
integrin [7], and the migration of hematopoietic progeni-
tor cells from the fetal blood into the fetal liver during
early development. In early hematopoietic development,
we could show that genetic deletion of the b1 integrin
gene in progenitor cells leads to their accumulation in the
fetal blood and hence the inability to populate hemato-
poietic tissues [7,17]. Although it is likely that a4 is of
major importance in this setting, other a chains may be
involved. A possible candidate is the largely neglected
integrin a9b1, which is highly expressed on granulocytes
and binds to VCAM-1 and the ECM proteins tenascin,
osteopontin and fibronectin. a9b1 has been shown to
mediate transendothelial migration in vitro via interaction
with VCAM-1 [18]. Interestingly, a4 and a9 chain are
closely related and together form a sub-family that binds
to the cytoplasmic adaptor paxillin [19].
Migration through the endothelium
Tight adhesion to the endothelium is followed by a
cascade of migration events that probably successively
trigger each other. First the cells have to pass through the
endothelial monolayer. There is no in vivo evidence that
this process — called ‘diapedesis’ — is directly depen-
dent on b1 integrins. It is rather mediated by cell adhe-
sion molecules of the JAM family, CD99 and PECAM-1
[1]. Nevertheless, ligation of endothelial VCAM-1 via
a4b1 seems to be a prerequisite for diapedesis, as it
triggers a signal within the endothelial cell that is trans-
mitted via the cytoplasmic tail of VCAM [20]. The
endothelial cell then reacts by actively extending protru-
sions to capture and guide the extravasating cell through
intercellular junctions or by transcytosing it directlyCurrent Opinion in Cell Biology 2006, 18:482–490
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Figure 1
Roles of b1 integrins during extravasation, interstitial migration and lymphocyte activation. (a) During selectin-mediated rolling, the extravasating
cell senses chemokines that are immobilized on the surface of the endothelium, leading to the inside-out activation of integrin a4b1. (b) The
a4b1–VCAM-1 interaction mediates firm adhesion and triggers a reverse signal via VCAM-1 that induces the extension of endothelial protrusions,
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[20,21].
Transmigration through the basement
membrane
All the events following diapedesis are far less character-
ized, which is mainly due to their experimental inacces-
sibility and the lack of established in vitro models to study
molecular interactions. Directly after passing through the
endothelium, the transmigrating cells face a seemingly
impermeable barrier of ECM: the endothelial basement
membrane (BM). BMs are tightly interconnected and
thin (50–100 nm) sheets of specialized ECM compo-
nents of the laminin and collagen IV family [22]. It is
possible that b1 integrins play an active role during this
passage and in vitro studies have demonstrated that
leukocytes can actively bind BM components [23]. If
BM transmigration is selectively blocked in vivo one
would expect that extravasating leukocytes become
trapped between the endothelial cell layer and the under-
lying BM. Indeed this phenomenon was observed when
extravasation of granulocytes triggered by interleukin
(IL)-1 was studied in mice in which platelet endothelial
cell adhesion molecule-1 (PECAM-1) was functionally
inactivated by blocking antibodies or genetic deletion
[24]. The homophilic interaction between PECAM-1 on
granulocyte and endothelium induced the up-regulation
of the laminin binding a6b1 integrin on the granulocyte
surface, which in turn was necessary for BM transmigra-
tion [25]. Although this sequence of events was well
demonstrated in this specific experimental setting, it is
not a general phenomenon, as granulocyte extravasation
in response to tumor necrosis factor (TNF)a occurred
independently of PECAM-1 and a6b1 [26]. Another
recently reported example of the possible involvement
of a BM binding integrin during extravasation is the
reduced homing of hematopoietic stem cells into the
bone marrow after antibody blockade of a6b1 [27].
A physiologically distinct situation where leukocytes
cross a BM occurs during the emigration of Langerhans
cells from the epidermis. Their penetration through the
epidermal BM (which is biochemically distinct from
blood vessel BMs [28]) can also be inhibited by antibody
blockade of a6 integrin [29]. Although in this case it
remains to be shown which b chain (b1 or b4) pairs with
a6, laminin is the likely ligand.
Apart from these fragmentary data about molecular
players, the progression of physiological events that leads
to BM transmigration is completely enigmatic.(Figure Legend 1 continued) establishing a ‘docking structure’. (c) Diaped
(not shown). Signals from the endothelium induce surface expression of a6b
laminin-binding integrin a6b1 and cell surface proteases mediate passage o
follicular dendritic cells and B cells and dendritic cells and T cells where it p
chemotactic gradients is possibly mediated by the collagen-binding a2b1 in
www.sciencedirect.comProteolytic digestion via proteases, especially by the
matrix metalloproteinase (MMP) family, has been sug-
gested in several ex vivo models [30,31]. In this context it
is interesting that ligation of integrins can lead to the
induction of MMPs on leukocytes [31,32]. It remains to
be shown if integrins merely signal the presence of a BM
to induce proteolytic cascades or other events leading to
the BM’s local disassembly, or if integrin-mediated adhe-
sion is also a physical requirement for the translocation of
the cell body through the BM.
Migration through the interstitium
The diverse extracellular environments that leukocytes
face upon passaging through the BM range from the
loosely packed and fibrillar-collagen-dominated connec-
tive tissue of the mesenchymal interstitium to the
cell-rich environment of secondary lymphatic organs.
At this stage, true directed migration takes over and it
is assumed that leukocytes navigate along gradients of
chemotactic agents towards their destinations. Despite
numerous in vitro studies using artificial settings such as
transwell filters coated with ECM components, it is still
controversial if this directed migration depends on integ-
rins at all in vivo. The most direct experimental evidence
for integrin involvement is provided by a series of intra-
vital microscopy studies revealing that migration of gran-
ulocytes through the mesenteric interstitium can be
partially inhibited by blocking antibodies against the
collagen-binding b1 and a2 integrin chains [33–35].
However, measured reductions in speed of only 30%
raise the question of whether the remaining migratory
activity is mediated by compensating (b2 or av) integrins
or whether it is completely integrin-independent. In vitro
experimental approaches using three-dimensional gels of
the fibrillar collagens I and III, which mimic the inter-
stitial ECM, can be utilized as migration matrices and
studied by video microscopy. Even in this artificial and
very defined setting, the results obtained with integrin-
blocking antibodies are controversial. By combined anti-
body blockade of av, b2 and b1 integrins, it was shown
that random T cell migration in the gel can occur in an
‘ameboid’ fashion in the complete absence of integrin-
mediated binding [36] and proteolytic activity [37]. How-
ever, others demonstrated that in the presence of che-
motactic agents, T cells utilize b1 (a1, a2, a6) integrins
for locomotion within collagen gels [38]. Although the
issue of interstitial migration remains to be clarified using
genetic approaches in combination with intravital micro-
scopy, it is evident that it is essential to define not only the
nature of the ECM ligand but also the spatial configura-
tion of the extracellular environment in order to establishesis is mediated via PECAM-1, JAMs, CD99 and b2 integrins
1 and proteases on the transmigrating cell. (d,e) In some cases the
f the basement membrane. (f) a4b1 localizes to synapses between
romotes lymphocyte activation. (g) Interstitial migration along
tegrin.
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[39] showed that in the spatially constrained environment
of a narrow space between two closely adjacent glass
surfaces, granulocytes can switch to biophysical mechan-
isms of translocation (squeezing or ‘chimneying’) that are
independent of integrin binding. By contrast, on two
dimensional surfaces granulocytes are completely depen-
dent on integrins to generate traction forces [39]. These
findings impressively demonstrate the importance of
using 3-dimensional model systems to study interstitial
blood cell migration.
In the light of these diverse and partially controversial
data, it seems possible that within the 3-dimensional
environment of the interstitium the quickly migrating
blood cells employ adhesive mechanisms that are funda-
mentally different from the integrin-dependent migra-
tion strategies used by mesenchymal cells.
Retention and positioning within the tissue
While it still remains to be clarified to what extent
integrins are involved in interstitial leukocyte migration,
there is solid evidence that integrin-mediated binding can
define the position of hematopoietic cells by immobiliz-
ing and retaining them in their niches. Owing to the poor
knowledge about the spatial configuration and molecular
composition of these niches, it is not known if retention
simply reflects integrin-mediated cell binding or if more
complex processes are triggered via integrin signaling that
ultimately lead to retention. Two prominent examples of
integrin-mediated retention are illustrated by studies
involving marginal zone B cells and hematopoietic pro-
genitor cells.
Several studies revealed that different precursors can be
released from the bone marrow by antibody blockade or
genetic inactivation of the a4 integrin [40,41]. Similar
results were obtained with mice lacking the a4b1 ligand
VCAM-1 [42]. It has been proposed that in the bone
marrow the stroma-derived chemokine CXCL12 triggers
a sustained signal that keeps the integrin in the active
state and therefore immobilizes the cells to VCAM-1 and
fibronectin on stroma cells [43].
Marginal zone B cells are part of the first line defense
system against circulating soluble antigens. As such, they
are located in a defined ring area around the white pulp
follicles of the spleen, where they capture blood-borne
antigens. Only upon activation by microbial stimuli or
antigen do they downregulate integrin avidity, detach
from the marginal zone and follow a chemotactic gradient
of the chemokine CXCL13 that guides them into the
follicle, where they produce immunoglobulins. The
retention of marginal zone B cells is redundantly
mediated by a4b1 and aLb2 integrin, and blockade or
genetic ablation of these integrins causes the cells to
dislocate from the marginal zone [44]. In marginal zoneCurrent Opinion in Cell Biology 2006, 18:482–490B cells, integrin affinity was shown to be regulated via the
GTPase RhoA and the exchange factor lsc, as in the
absence of lsc these cells are unable to leave their niche
following stimulation owing to an insufficient down-mod-
ulation of integrin avidity [45].
An interesting series of studies that suggests a role for
integrin-mediated retention during pathological pro-
cesses has been performed by de Fougerolles and
co-workers. Using antibody blockade and genetic inactiva-
tion, they demonstrated that the collagen receptors a1b1
and a2b1 are critically involved in the course of cutaneous
hypersensitivity, experimental arthritis and colitis by
localizing T cells within the interstitium [46–48]. Further-
more, in two models of murine virus infection, the number
of virus-specific CD8 memory T cells in the lung of
infected animals could be reduced by anti-a1b1 adminis-
tration without affecting T cell recruitment during primary
infection [49,50]. Therefore it is likely that a1b1
is needed for the long term retention of CD8 memory
T cells in the lung.
Cell–cell interactions and activation of
lymphocytes
The initiating step in all T-cell-dependent immune
responses is the formation of an immunological synapse
— the contact between an antigen-presenting cell (B
cell or dendritic cell) and a T cell. A main functional
constituent of the synapse is a sealing zone (the periph-
eral supramolecular activation cluster or pSMAC), which
is defined and maintained by the interaction of LFA1
on the T cell with ICAM 1 on the antigen presenting
cell.
Although early in vitro studies already suggested that b1
integrins have potent co-stimulatory functions, condi-
tional knockout mice lacking b1 integrins on hemato-
poietic cells showed a relatively weak immunological
phenotype: T-cell-dependent immune responses were
grossly unaffected with the surprising exception that
IgM production was severely decreased [15]. However,
recent data suggest that members of the b1 integrin
family might play a more subtle regulatory role during
immune synapse formation. Mittelbrunn et al. showed
that a4b1, like aLb2, localizes within the pSMAC of
synapses between T cells and dendritic cells/B cells.
Furthermore, they could demonstrate that this interaction
is important for shifting of the T cells towards a Th1-type
cellular immune response [51]. Another recent study
showed that B cells utilize a4b1 to bind VCAM-1 co-
expressed with antigen on the surface of fibroblasts in
vitro, which might reflect B cell interaction with follicular
dendritic cells in the lymph node [52,53]. Moreover, it
could be shown that this interaction synergizes with the B
cell receptor signal and triggers B cell activation. It will be
important to test if integrins assist T/B cell receptor
signaling only indirectly, by establishing and maintainingwww.sciencedirect.com
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the signaling pathways triggered by both receptors.
Members of the b1 integrin subfamily as
anti-inflammatory drug targets
Pharmacological interference with leukocyte extravasa-
tion is an attractive strategy for anti-inflammatory thera-
pies that was sparked off by the discovery of the
extravasation paradigm in the late 1980s. Table 1 lists
some selected diseases where blockade of b1 integrins
showed beneficial effects, together with a proposed
mechanism of action. Although the intended therapeutic
effect of most of these therapeutic approaches involves the
inhibition of firm adhesion to the endothelium, it is not
clear whether other processes, for example lymphocyte
activation, could be affected as well. A prominent example
of this uncertainty is autoimmune inflammation of the
central nervous system. It is well established that the
binding of lymphocytes to inflamed brain blood vessels
during experimental autoimmune encephalomyelitis in
rodents is inhibited by antibodies against a4b1 and that
these antibodies prevent the development of the disease
[16]. This therapeutic principle was used in a clinical trial
to treat patients suffering from the equivalent human
disease, multiple sclerosis [54]. Despite very promising
results, approximately one out of thousand patients
acquired a deadly opportunistic viral infection of theTable 1
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Colitis
(mouse)
a1b1 Reduced clinical sy
nflammatory infiltra
and TNF-a product
a1 deficiency; anti-a1 mAb
CNS, central nervous system; EAE, experimental autoimmune encephalom
www.sciencedirect.comCNS during chronic treatment [55]. These could have
been caused either by impaired trafficking of non-patho-
genic lymphocytes that are essential for normal CNS
immunosurveillance or by a more general immunosup-
pression. Indeed it has been shown in rodent EAE that an
anti-a4 antibody which does not inhibit lymphocyte hom-
ing in vivo still ameliorates EAE [56]. This argues in favor
of an additional role for a4b1 apart from mediating extra-
vasation. In this context the recent data suggesting a role
for a4b1 in T cell activation are of special interest.
Conclusions
Advances in the field of intravital imaging make it now
possible to track the dynamic behavior of cells in most
tissues of living animals. In combination with genetic
models where integrins are specifically deleted on
defined blood cell lineages, this approach will allow the
pinpointing of many of the cell biological roles of b1
integrins on hematopoietic cells. This knowledge will be
decisive to predict side effects when pharmacological
approaches are developed in which integrins are targeted
in a non-cell-type-specific manner. Investigating cyto-
plasmic players involved in the activation of the b1
integrins will further teach us to what extent the signaling
pathways are cell-type- and a-chain-specific and will
eventually reveal new drug targets to inhibit extravasation
in a more cell- and tissue-type-specific manner.nhibition Proposed mode of action References
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